Gilead Sciences Inc
NASDAQ: GILD
$94.35
-$2.68 (-2.8%)
Closing Price on November 12, 2024
GILD Articles
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Here are 30 stocks with sustainable dividends for income investors to consider in their portfolios.
Published:
Last Updated:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Stocks saw profit-taking on Tuesday, but the major indexes were up on Wednesday ahead of the Federal Reserve’s expected interest rate cut in the afternoon. Earnings season is proving to be quite...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included Aflac, Apple, Chipotle Mexican Grill, Coca-Cola, Dell Technologies, Dish Network, Gilead Sciences, McDonald's and...
Published:
Last Updated:
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations on Monday included Agilent Technologies, Amazon.com, American Water Works, Crocs, Deere, General Electric, Gilead Sciences, Slack and Teva...
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Published:
Last Updated:
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
Published:
Last Updated:
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
Published:
Last Updated:
Goldman Sachs has muted any upside view by downgrading Gilead Sciences to Sell and lowering its price target.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated: